UPC Court of Appeal hears crucial transparency test case
IAM speaks to both sides following landmark document access hearing
Stay updated with breaking news from Simon Ayrton. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
IAM speaks to both sides following landmark document access hearing
Parties reach agreement in global patent dispute over robotic warehousing technology
Feb 02, 2021 Ben Edwards In early-December, just weeks before AstraZeneca’s coronavirus vaccine began receiving regulatory approval around the world, the Cambridge-headquartered drugmaker agreed a $39-billion deal to buy US biotech firm Alexion. The size of the transaction was driven, in part, by Alexion’s pipeline of rare blood disease treatments and its blockbuster drug Soliris. Such medicines are often the driver of bumper mergers and acquisitions in the pharmaceutical industry because of the power of patents, a type of intellectual property (IP) protection that prevents others from ...